Lawson-Tovey, Saskia http://orcid.org/0000-0002-8611-162X
Smith, Samantha Louise http://orcid.org/0000-0002-4108-8497
Geifman, Nophar http://orcid.org/0000-0003-2956-6676
Shoop-Worrall, Stephanie http://orcid.org/0000-0002-9441-5535
Ng, Sandra http://orcid.org/0000-0003-4524-6058
Barnes, Michael R. http://orcid.org/0000-0001-9097-7381
Wedderburn, Lucy R. http://orcid.org/0000-0002-7495-1429
Hyrich, Kimme L. http://orcid.org/0000-0001-8242-9262
Kartawinata, Melissa
Wanstall, Zoe
Jebson, Bethany R.
McNeece, Alyssia
Ralph, Elizabeth
Alexiou, Vasiliki
Dekaj, Fatjon
Kimonyo, Aline
Merali, Fatema
Sumner, Emma
Robinson, Emily
Feilding, Freya L.
Dick, Andrew
Beresford, Michael W.
Carlsson, Emil
Fairlie, Joanna
Gritzfeld, Jenna F.
Ramanan, Athimalaipet
Duerr, Teresa
Eyre, Stephen
Raychaudhuri, Soumya
Morris, Andrew
Yarwood, Annie
Smith, Samantha
Bowes, John
Martin, Paul
Tordoff, Melissa
Stadler, Michael
Thomson, Wendy
Tarasek, Damian
Wallace, Chris
Lin, Wei-Yu
Clarke, Sarah
Kent, Toby
Sornasse, Thierry
Dastros-Pitei, Daniela
Mukherjee, Sumanta
Roberts, Jacqui
Kallala, Rami
Neale, Helen
Ioannou, John
Al-Mossawi, Hussein
,
Funding for this research was provided by:
Medical Research Council (MR/R013926/1)
Versus Arthritis (22084)
Great Ormond Street Hospital Charity (VS0518)
AbbVie
Swedish Orphan Biovitrum
Olivia's Vision
Article History
Received: 19 January 2023
Accepted: 1 June 2023
First Online: 13 July 2023
Declarations
:
: All studies contributing data to the current CLUSTER dataset have appropriate approvals in place for data re-use for further research.
: Not applicable.
: The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health.
: SLT, SS, NG, SSW, SN have nothing to disclose. MRB reports grant income from Abbvie unrelated to this work. LRW reports non-personal consulting fees from Pfizer unrelated to this work; LRW is supported by the NIHR Great Ormond Street Biomedical Research Centre. KLH reports she has received non-personal speaker’s fees from Abbvie and grant income from BMS and Pfizer, all unrelated to this manuscript; KLH is supported by the NIHR Manchester Biomedical Research Centre.